Company: WHWK
Filing Date: 2025-03-04
Form Type: 8-K
Source: 0001193125-25-045605
Chunk: 3

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-04
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                     
                                                                                                               
   Number                                                                                                      
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Registration Rights Agreement, by and among Aadi Biosciences, Inc. and the purchasers thereto.  
     10.2      Amended and Restated 2021 Equity Incentive Plan.                                                
     99.1      Press Release, dated March 4, 2025                                                              
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                     

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                     AADI BIOSCIENCE, INC.    
  March 4, 2025      /s/ Scott Giacobello     
                     Scott Giacobello         
                     Chief Financial Officer